BCL2 and Lymphadenopathy: Bcl2-Tg mice developed lymphadenopathy and splenomegaly and died around 60 weeks (median survival of 64 weeks, Figure 2A), which is significantly shorter than wild-type mice suggesting follicular lymphoma development as reported.